MedPath

High fetal catecholamines - a cause for neonatal hypoglycemia and transient hyperinsulinism?

Conditions
E16.1
P70.4
Other hypoglycaemia
Other neonatal hypoglycaemia
Registration Number
DRKS00022471
Lead Sponsor
niversitätsklinikum Düsseldorf
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
299
Inclusion Criteria

Pregnant women with their unborn child: participants will be assigned to the risk group if the child is IUGR, SGA (birth weight <10th percentile), LGA (birth weight >10th percentile), premature (35+0-36+6 weeks of gestation), has a mother with diabetes/gestational diabetes, pre-/eclampsia or if the child suffers from birth asphyxia. Children without any of the above-mentioned risk factors will be assigned to the control group.

Exclusion Criteria

Lack of parental consent. Prematurity <35+0 weeks of gestation.

Study & Design

Study Type
observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
1) Do infants with different risk factor for hypoglycemia (SGA, IUGR, LGA, late preterm, asphyxiated or have a mother with diabetes or pre-/eclampsia etc.(data will be obtained from the medical file) have higher levels of catecholamines in AF and/or arterial cord blood compared to a control group without risk factors (at the time of birth)? <br><br>2) Do higher levels of catecholamines/its metabolites (in amniotic fluid and/or arterial cord blood at the time of birth) correlate with lower blood glucose levels and longer duration of hypoglycemia (regular blood glucose measurements will be done according to the SOP of our hospital)?
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath